Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Saga warns of profits dip in current year, reiterates long-term outlook

(Sharecast News) - Travel-to-publishing group Saga posted a jump in annual earnings on Wednesday, but warned the coming year would be "one of transition", leading to weaker profits. The group, a specialist in products and services for the over 50s, said underlying revenues improved 5% in the year to 31 January, to £768.2m.

Revenues rose 4%, at £588.3m, while underlying pre-tax profits from continuing operations strengthened 8% at £37.2m.

Total underlying profits jumped 25% to £47.8m, ahead of guidance.

Saga's travel arm drove the jump in profits, following strong demand for its river and ocean cruises.

During the year, Saga agreed to sell its insurance underwriting business to Belgium's Ageas, with whom it also signed a 20-year insurance broking partnership.

Mike Hazell, chief executive, said: "These achievements materially reduce the risk and complexity of our insurance business going forward, and when combined with our continued strong trading performance, meant that we were able to complete the financing of our long-term corporate debt."

However, looking to current year, Saga acknowledged it would be "one of transition".

"Our travel businesses will deliver further growth, supported by their strong forward bookings position," it said. "Alongside this we will continue to prepare for the sale of our insurance underwriting business and...new partnership arrangement with Ageas.

"A material increase in financing costs will mean that we expect the group to generate an underlying pre-tax profit below that of 2024/25, before returning to growth thereafter."

Hazell added: "I am confident that the plans we have in place will step change our financial performance within the next five years, delivering a business with annual underlying profits of at least £100m."

Saga also announced that following the insurance deals, senior independent director Peter Bazalgette and insurance chief executive Steve Kingshott had stepped down from the board.

Sage said the move reflected the company's "new, simplified business model".

Gareth Hoskin replaces Bazalgette as chair of the nomination committee and senior independent director.

As at 0900 BST, shares in the FTSE All Share stock were up just under 1% at 126.2p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.